Symbols

ACH

Accendra Health·NYSE

--(--)

ACH fundamentals

ACH Q4 2025 Earnings

Accendra Health (ACH) released its earnings on Feb 19, 2026: revenue was 708.97M (YoY -73.70%), missed estimates; EPS was 0.21 (YoY -61.82%), missed estimates.

Revenue / YoY

708.97M

-73.70%

EPS / YoY

0.21

-61.82%

Report date

Feb 19, 2026

ACH Earnings Call Summary for Q4,2025

Revenue & EBITDA Decline: 2025 revenue $2.8B (flat YoY), EBITDA $375M (flat YoY). 2026 guidance: Revenue $2.55-2.65B (-5-8%), EBITDA $335-355M (-6-11%).
Debt Reduction Progress: Net debt down to $1.8B (from $2.2B in 2024), with $65M reduction in Q4. Target leverage ratio 3x EBITDA.
Strategic Focus: Technology investments (MyApria app launch Q2 2026), sleep therapy growth (8-9% YoY), and cost reduction initiatives to offset $300M revenue loss from a large payer.
Free Cash Flow: Midpoint $100M in 2026, supporting debt deleveraging and strategic investments.

Earnings

EPS

Revenue

Revenue & Expenses

ACH has released its 2025 Q4 earnings report, with revenue of 708.97M, reflecting a YoY change of 2.01%, and net profit of -56.33M, showing a YoY change of 80.98%. The Sankey diagram below clearly presents ACH's revenue sources and cost distribution.

Key Indicators

Accendra Health (ACH) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Accendra Health (ACH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Accendra Health (ACH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Accendra Health (ACH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown